Is It Still Worth Buying GSK After a 46% Rally in Shares This Year
GSK has seen a steep run in its stock, prompting questions about whether the rally still offers upside. This article ...
In 2024, comparing Itot and Vti costs helps identify the more economical choice for long-term retirement goals.
28,280 articlesGSK has seen a steep run in its stock, prompting questions about whether the rally still offers upside. This article ...
Zoom's post-pandemic growth trajectory remains uncertain as investors weigh AI opportunities and competition. This pi...
JPMorgan has begun a pilot that compares junior bankers' self-reported hours to computer activity, including keystrok...
Y Combinator will conduct crypto-focused startup interviews in New York for the first time, highlighting NYC's growin...
The Clarity Act is moving toward markup with more than 100 amendments, spotlighting a fierce clash over stablecoin re...
AI-driven momentum puts Apple on a path to a potential $6 trillion valuation, as investors weigh WWDC 2026 plans and ...
A new advocacy group backing Kalshi’s prediction market efforts has publicly launched in Washington, with former Whit...
When a stock climbs 250% in a year, funds often trim positions to lock in gains and manage risk. This article explain...
A former IBM cybersecurity executive alleges repeated foreign breaches on IBM and AT&T networks and claims the compan...
Figure Technology Solutions is acquiring Kiavi in a $717 million deal, expanding its first-lien lending and investor-...
DTE Energy is carving out a leading role in AI infrastructure, backed by new hyperscaler deals, a ramped-up capital p...
This article explores Baupost founder Seth Klarman's patient, risk-conscious investing style. Learn how his focus on ...